World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
40309
World Ranking
7344
National Ranking
717

Neuroscience

D-Index
103
Citations
40308
World Ranking
683
National Ranking
84

Patricia Limousin publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Patricia Limousin sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 417 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Patricia Limousin D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Patricia Limousin sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 103 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Patricia Limousin is affiliated with University College London in the United Kingdom. Their research primarily focuses on neurology and neuroscience, with a particular emphasis on neurological disorders and treatments, especially Parkinson's disease mechanisms and treatments.

Their extensive body of work spans 144 publications in medicine and 49 in neuroscience. Subfields include neurology with 138 publications, cellular and molecular neuroscience with 21, cognitive neuroscience with 13, as well as physiology and clinical psychology with 4 publications each.

Limousin's frequent publication venues include:

  • Movement Disorders Clinical Practice
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Stereotactic and Functional Neurosurgery
  • Movement Disorders
  • npj Parkinson's Disease

Key topics covered in their research are:

  • Neurological disorders and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Transcranial Magnetic Stimulation Studies
  • Botulinum Toxin and Related Neurological Disorders
  • Genetic Neurodegenerative Diseases
  • Neuroscience and Neural Engineering
  • Parkinson's Disease and Spinal Disorders

Patricia Limousin has collaborated frequently with several researchers, including:

  • Thomas Foltynie (56 joint publications)
  • Ludvic Zrinzo (44 joint publications)
  • Harith Akram (36 joint publications)
  • Jonathan Hyam (14 joint publications)
  • Nirosen Vijiaratnam (11 joint publications)

Selected recent publications include:

  • Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations, 2020, JAMA Neurology
  • Neural signatures of hyperdirect pathway activity in Parkinson's disease, 2021, Nature Communications
  • How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?, 2022, Movement Disorders
  • Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study, 2021, BMJ Open
  • Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial, 2025, The Lancet

Best Publications

  • Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

    Paul Krack;Alina Batir;Nadège Van Blercom;Stephan Chabardes

  • Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease

    Patricia Limousin;Paul Krack;Pierre Pollak;Abdelhamid Benazzouz

  • Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

    P. Limousin;P. Pollak;A. Benazzouz;D. Hoffmann

  • Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders

    Alim Louis Benabid;Pierre Pollak;Dongming Gao;Dominique Hoffmann

  • Adaptive deep brain stimulation in advanced Parkinson disease

    Simon Little;Alex Pogosyan;Spencer Neal;Baltazar Zavala

  • Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance.

    Andrea A. Kühn;David Williams;Andreas Kupsch;Patricia Limousin

  • Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    Dilan Athauda;Kate Maclagan;Simon S Skene;Martha Bajwa-Joseph

  • Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.

    Paul Krack;Pierre Pollak;P Limousin;D Hoffmann

  • Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.

    P Limousin;J D Speelman;F Gielen;M Janssens

  • Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease.

    Patricia Limousin;John Greene;Pierre Pollak;John Rothwell

  • Exenatide and the treatment of patients with Parkinson’s disease

    Iciar Aviles-Olmos;John Dickson;Zinovia Kefalopoulou;Atbin Djamshidian

  • Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients

    C. Ardouin;B. Pillon;E. Peiffer;P. Bejjani

  • α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

    Aoife P. Kiely;Yasmine T. Asi;Eleanna Kara;Patricia Limousin;Patricia Limousin

  • Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease

    Vladimir Litvak;Vladimir Litvak;Ashwani Jha;Ashwani Jha;Alexandre Eusebio;Robert Oostenveld

  • Long-Term Electrical Inhibition of Deep Brain Targets in Movement Disorders

    A L Benabid;A Benazzouz;D Hoffmann;P Limousin

  • Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease

    L.A. Robak;L.A. Robak;I.E. Jansen;I.E. Jansen;J van Rooij;A.G. Uitterlinden

  • Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

    Suzanne Lesage;Valérie Drouet;Elisa Majounie;Vincent Deramecourt

  • Long-term outcomes of deep brain stimulation in Parkinson disease

    Patricia Limousin;Tom Foltynie

  • Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

    A. Beilina;I. N. Rudenko;A. Kaganovich;L. Civiero

  • Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review.

    Ludvic Zrinzo;Thomas Foltynie;Patricia Limousin;Marwan I. Hariz;Marwan I. Hariz

  • Opposite motor effects of pallidal stimulation in Parkinson's disease.

    Paul Krack;Pierre Pollak;P Limousin;D Hoffmann

Frequent Co-Authors

Marwan Hariz
Marwan Hariz Umeå University
Thomas Foltynie
Thomas Foltynie University College London
Ludvic Zrinzo
Ludvic Zrinzo University College London
Peter Brown
Peter Brown University of Oxford
Marjan Jahanshahi
Marjan Jahanshahi University College London
Kailash P. Bhatia
Kailash P. Bhatia University College London
Andrew J. Lees
Andrew J. Lees University College London
Huiling Tan
Huiling Tan University of Oxford
Alek Pogosyan
Alek Pogosyan University of Oxford
Alexander L. Green
Alexander L. Green University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in neuroscience, you may also want to explore related online degrees and diverse career pathways in mental health and behavioral sciences. Many students opt for online programs such as marriage and family masters programs, which offer a direct route to working with families and couples in clinical settings.

A masters in psychology online can open doors to a wide variety of roles, from research to counseling. Cost is an important factor—prospective students should compare the psychology degree cost across accredited programs to find an option that fits their budget.

Additionally, those interested in social work can consider msw programs with high acceptance rate. These programs may offer a more accessible pathway for career entry while still providing valuable training for a range of clinical and community roles.

Exploring these options can help you find the best fit for your professional goals in neuroscience and related fields.

Best Scientists Citing Patricia Limousin

Trending Scientists

Recently Published Articles